A citation-based method for searching scientific literature

Violena Pietrobon, Lauren Anne Todd, Anghsumala Goswami, Ofir Stefanson, Zhifen Yang, Francesco Marincola. Int J Mol Sci 2021
Times Cited: 5







List of co-cited articles
8 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia.
Shannon L Maude, Theodore W Laetsch, Jochen Buechner, Susana Rives, Michael Boyer, Henrique Bittencourt, Peter Bader, Michael R Verneris, Heather E Stefanski, Gary D Myers,[...]. N Engl J Med 2018
60

Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma.
Sattva S Neelapu, Frederick L Locke, Nancy L Bartlett, Lazaros J Lekakis, David B Miklos, Caron A Jacobson, Ira Braunschweig, Olalekan O Oluwole, Tanya Siddiqi, Yi Lin,[...]. N Engl J Med 2017
60

Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
Stephen J Schuster, Michael R Bishop, Constantine S Tam, Edmund K Waller, Peter Borchmann, Joseph P McGuirk, Ulrich Jäger, Samantha Jaglowski, Charalambos Andreadis, Jason R Westin,[...]. N Engl J Med 2019
60

Human CAR T cells with cell-intrinsic PD-1 checkpoint blockade resist tumor-mediated inhibition.
Leonid Cherkassky, Aurore Morello, Jonathan Villena-Vargas, Yang Feng, Dimiter S Dimitrov, David R Jones, Michel Sadelain, Prasad S Adusumilli. J Clin Invest 2016
548
40

Pembrolizumab for B-cell lymphomas relapsing after or refractory to CD19-directed CAR T-cell therapy.
Elise A Chong, Cécile Alanio, Jakub Svoboda, Sunita D Nasta, Daniel J Landsburg, Simon F Lacey, Marco Ruella, Siddharth Bhattacharyya, E John Wherry, Stephen J Schuster. Blood 2022
17
40

Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia.
Jae H Park, Isabelle Rivière, Mithat Gonen, Xiuyan Wang, Brigitte Sénéchal, Kevin J Curran, Craig Sauter, Yongzeng Wang, Bianca Santomasso, Elena Mead,[...]. N Engl J Med 2018
40

The tyrosine kinase inhibitor dasatinib acts as a pharmacologic on/off switch for CAR T cells.
Katrin Mestermann, Theodoros Giavridis, Justus Weber, Julian Rydzek, Silke Frenz, Thomas Nerreter, Andreas Mades, Michel Sadelain, Hermann Einsele, Michael Hudecek. Sci Transl Med 2019
200
40

CD19 CAR-T cells of defined CD4+:CD8+ composition in adult B cell ALL patients.
Cameron J Turtle, Laïla-Aïcha Hanafi, Carolina Berger, Theodore A Gooley, Sindhu Cherian, Michael Hudecek, Daniel Sommermeyer, Katherine Melville, Barbara Pender, Tanya M Budiarto,[...]. J Clin Invest 2016
40

Mechanisms of resistance to CAR T cell therapy.
Nirali N Shah, Terry J Fry. Nat Rev Clin Oncol 2019
381
20

LSD1 Ablation Stimulates Anti-tumor Immunity and Enables Checkpoint Blockade.
Wanqiang Sheng, Martin W LaFleur, Thao H Nguyen, Sujun Chen, Ankur Chakravarthy, Jake Ryan Conway, Ying Li, Hao Chen, Henry Yang, Pang-Hung Hsu,[...]. Cell 2018
289
20


Long-Term Persistence of Exhausted CD8 T Cells in Chronic Infection Is Regulated by MicroRNA-155.
Erietta Stelekati, Zeyu Chen, Sasikanth Manne, Makoto Kurachi, Mohammed-Alkhatim Ali, Keith Lewy, Zhangying Cai, Kito Nzingha, Laura M McLane, Jennifer L Hope,[...]. Cell Rep 2018
54
20

T Cell Dysfunction and Exhaustion in Cancer.
Zhen Zhang, Shasha Liu, Bin Zhang, Liang Qiao, Yi Zhang, Yi Zhang. Front Cell Dev Biol 2020
113
20

miR-155 indicates the fate of CD4+ T cells.
Li Chen, Dian Gao, Zhaozhao Shao, Qiaoyu Zheng, Qiongfang Yu. Immunol Lett 2020
12
20

Simultaneous Inhibition of LSD1 and TGFβ Enables Eradication of Poorly Immunogenic Tumors with Anti-PD-1 Treatment.
Wanqiang Sheng, Yi Liu, Damayanti Chakraborty, Brian Debo, Yang Shi. Cancer Discov 2021
13
20

miR-155 harnesses Phf19 to potentiate cancer immunotherapy through epigenetic reprogramming of CD8+ T cell fate.
Yun Ji, Jessica Fioravanti, Wei Zhu, Hongjun Wang, Tuoqi Wu, Jinhui Hu, Neal E Lacey, Sanjivan Gautam, John B Le Gall, Xia Yang,[...]. Nat Commun 2019
44
20

Histone demethylase LSD1 regulates hematopoietic stem cells homeostasis and protects from death by endotoxic shock.
Jianxun Wang, Kaoru Saijo, Dylan Skola, Chunyu Jin, Qi Ma, Daria Merkurjev, Christopher K Glass, Michael G Rosenfeld. Proc Natl Acad Sci U S A 2018
21
20

miR-155 Overexpression in OT-1 CD8+ T Cells Improves Anti-Tumor Activity against Low-Affinity Tumor Antigen.
Gwennaëlle C Monnot, Amaia Martinez-Usatorre, Evripidis Lanitis, Silvia Ferreira Lopes, Wan-Chen Cheng, Ping-Chih Ho, Melita Irving, George Coukos, Alena Donda, Pedro Romero. Mol Ther Oncolytics 2019
7
20

MicroRNA-155 is required for effector CD8+ T cell responses to virus infection and cancer.
Jan C Dudda, Bruno Salaun, Yun Ji, Douglas C Palmer, Gwennaelle C Monnot, Estelle Merck, Caroline Boudousquie, Daniel T Utzschneider, Thelma M Escobar, Rachel Perret,[...]. Immunity 2013
209
20

Proinflammatory Mediators, IL (Interleukin)-1β, TNF (Tumor Necrosis Factor) α, and Thrombin Directly Induce Capillary Tube Regression.
Gretchen M Koller, Christopher Schafer, Scott S Kemp, Kalia N Aguera, Prisca K Lin, Joshua C Forgy, Courtney T Griffin, George E Davis. Arterioscler Thromb Vasc Biol 2020
21
20

A versatile system for rapid multiplex genome-edited CAR T cell generation.
Jiangtao Ren, Xuhua Zhang, Xiaojun Liu, Chongyun Fang, Shuguang Jiang, Carl H June, Yangbing Zhao. Oncotarget 2017
231
20

The effect of cellular context on miR-155-mediated gene regulation in four major immune cell types.
Jing-Ping Hsin, Yuheng Lu, Gabriel B Loeb, Christina S Leslie, Alexander Y Rudensky. Nat Immunol 2018
68
20

CAR-T Cell Therapy in Cancer: Tribulations and Road Ahead.
Qingyang Zhang, Jieming Ping, Zirui Huang, Xiaoli Zhang, Jingyi Zhou, Gangyang Wang, Shaoyang Liu, Jianjun Ma. J Immunol Res 2020
28
20

LSD1/KDM1A inhibitors in clinical trials: advances and prospects.
Yuan Fang, Guochao Liao, Bin Yu. J Hematol Oncol 2019
143
20

Bortezomib Sustains T Cell Function by Inducing miR-155-Mediated Downregulation of SOCS1 and SHIP1.
Ariana N Renrick, Menaka C Thounaojam, Maria Teresa P de Aquino, Evan Chaudhuri, Jui Pandhare, Chandravanu Dash, Anil Shanker. Front Immunol 2021
7
20

Chimeric antigen receptor T cell persistence and memory cell formation.
Alexander D McLellan, Seyed M Ali Hosseini Rad. Immunol Cell Biol 2019
96
20

Mechanisms of Relapse After CD19 CAR T-Cell Therapy for Acute Lymphoblastic Leukemia and Its Prevention and Treatment Strategies.
Xinjie Xu, Qihang Sun, Xiaoqian Liang, Zitong Chen, Xiaoli Zhang, Xuan Zhou, Meifang Li, Huilin Tu, Yu Liu, Sanfang Tu,[...]. Front Immunol 2019
108
20

Quantitative and time-resolved miRNA pattern of early human T cell activation.
Caroline Diener, Martin Hart, Tim Kehl, Stefanie Rheinheimer, Nicole Ludwig, Lena Krammes, Sarah Pawusch, Kerstin Lenhof, Tanja Tänzer, David Schub,[...]. Nucleic Acids Res 2020
5
20

Gfi1, a transcriptional repressor, inhibits the induction of the T helper type 1 programme in activated CD4 T cells.
Junpei Suzuki, Saho Maruyama, Hidekazu Tamauchi, Makoto Kuwahara, Mika Horiuchi, Masumi Mizuki, Mizuki Ochi, Tatsuya Sawasaki, Jinfang Zhu, Masaki Yasukawa,[...]. Immunology 2016
14
20

Upregulation of miR-155 in CD4(+) T Cells Promoted Th1 Bias in Patients With Unstable Angina.
Yanmei Chen, Lang Li, Yongguang Lu, Qiang Su, Yuhan Sun, Yang Liu, Dong Yang. J Cell Physiol 2015
14
20

Crystal Structure of the LSD1/CoREST Histone Demethylase Bound to Its Nucleosome Substrate.
Sang-Ah Kim, Jiang Zhu, Neela Yennawar, Priit Eek, Song Tan. Mol Cell 2020
33
20

Mechanism of Crosstalk between the LSD1 Demethylase and HDAC1 Deacetylase in the CoREST Complex.
Yun Song, Lisbeth Dagil, Louise Fairall, Naomi Robertson, Mingxuan Wu, T J Ragan, Christos G Savva, Almutasem Saleh, Nobuhiro Morone, Micha B A Kunze,[...]. Cell Rep 2020
41
20

Tranylcypromine Based Lysine-Specific Demethylase 1 Inhibitor: Summary and Perspective.
Xing-Jie Dai, Ying Liu, Xiao-Peng Xiong, Lei-Peng Xue, Yi-Chao Zheng, Hong-Min Liu. J Med Chem 2020
26
20

Interleukin-2 shapes the cytotoxic T cell proteome and immune environment-sensing programs.
Christina M Rollings, Linda V Sinclair, Hugh J M Brady, Doreen A Cantrell, Sarah H Ross. Sci Signal 2018
35
20

A review of currently identified small molecule modulators of microRNA function.
Emile N Van Meter, Jackline A Onyango, Kelly A Teske. Eur J Med Chem 2020
40
20

Prolonged Persistence of Chimeric Antigen Receptor (CAR) T Cell in Adoptive Cancer Immunotherapy: Challenges and Ways Forward.
Leila Jafarzadeh, Elham Masoumi, Keyvan Fallah-Mehrjardi, Hamid Reza Mirzaei, Jamshid Hadjati. Front Immunol 2020
39
20

MiR-155 is overexpressed in patients with atopic dermatitis and modulates T-cell proliferative responses by targeting cytotoxic T lymphocyte-associated antigen 4.
Enikö Sonkoly, Peter Janson, Marja-Leena Majuri, Terhi Savinko, Nanna Fyhrquist, Liv Eidsmo, Ning Xu, Florian Meisgen, Tianling Wei, Maria Bradley,[...]. J Allergy Clin Immunol 2010
215
20

Opposing LSD1 complexes function in developmental gene activation and repression programmes.
Jianxun Wang, Kathleen Scully, Xiaoyan Zhu, Ling Cai, Jie Zhang, Gratien G Prefontaine, Anna Krones, Kenneth A Ohgi, Ping Zhu, Ivan Garcia-Bassets,[...]. Nature 2007
403
20

The Transcription Factor T-Bet Is Regulated by MicroRNA-155 in Murine Anti-Viral CD8+ T Cells via SHIP-1.
Jennifer L Hope, Christopher J Stairiker, Panagiota I Spantidea, Donald T Gracias, Alison J Carey, Adam J Fike, Marjan van Meurs, Inge Brouwers-Haspels, Laurine C Rijsbergen, Joseph A Fraietta,[...]. Front Immunol 2017
20
20

MicroRNA-Mediated Metabolic Shaping of the Tumor Microenvironment.
Federico Virga, Lorena Quirico, Stefania Cucinelli, Massimiliano Mazzone, Daniela Taverna, Francesca Orso. Cancers (Basel) 2021
9
20

MicroRNA-155 Participates in the Expression of LSD1 and Proinflammatory Cytokines in Rheumatoid Synovial Cells.
Ziliang Yu, Hao Liu, Jianbo Fan, Feihu Chen, Wei Liu. Mediators Inflamm 2020
3
33

Mir-155, a central modulator of T-cell responses.
Evan F Lind, Pamela S Ohashi. Eur J Immunol 2014
53
20

Metabolic Control of Epigenetics and Its Role in CD8+ T Cell Differentiation and Function.
Cansu Yerinde, Britta Siegmund, Rainer Glauben, Carl Weidinger. Front Immunol 2019
20
20

T cell senescence and CAR-T cell exhaustion in hematological malignancies.
Dimitri Kasakovski, Ling Xu, Yangqiu Li. J Hematol Oncol 2018
131
20

CAR T Cells with Enhanced Sensitivity to B Cell Maturation Antigen for the Targeting of B Cell Non-Hodgkin's Lymphoma and Multiple Myeloma.
Julia Bluhm, Elisa Kieback, Stephen F Marino, Felix Oden, Jörg Westermann, Markus Chmielewski, Hinrich Abken, Wolfgang Uckert, Uta E Höpken, Armin Rehm. Mol Ther 2018
27
20

Tick-TOX, it's time for T cell exhaustion.
Thomas H Mann, Susan M Kaech. Nat Immunol 2019
33
20

Roles of IFN-γ in tumor progression and regression: a review.
Dragica Jorgovanovic, Mengjia Song, Liping Wang, Yi Zhang. Biomark Res 2020
155
20

Lysine-specific demethylase 1A restricts ex vivo propagation of human HSCs and is a target of UM171.
Agatheeswaran Subramaniam, Kristijonas Žemaitis, Mehrnaz Safaee Talkhoncheh, David Yudovich, Alexandra Bäckström, Shubhranshu Debnath, Jun Chen, Mayur Vilas Jain, Roman Galeev, Massimiliano Gaetani,[...]. Blood 2020
16
20

MicroRNA-155 Expression Is Enhanced by T-cell Receptor Stimulation Strength and Correlates with Improved Tumor Control in Melanoma.
Amaia Martinez-Usatorre, Lorenzo F Sempere, Santiago J Carmona, Laura Carretero-Iglesia, Gwennaëlle Monnot, Daniel E Speiser, Nathalie Rufer, Alena Donda, Dietmar Zehn, Camilla Jandus,[...]. Cancer Immunol Res 2019
18
20

Src/lck inhibitor dasatinib reversibly switches off cytokine release and T cell cytotoxicity following stimulation with T cell bispecific antibodies.
Gabrielle Leclercq, Hélène Haegel, Anneliese Schneider, Anna Maria Giusti, Estelle Marrer-Berger, Christophe Boetsch, Antje-Christine Walz, Vesna Pulko, Johannes Sam, John Challier,[...]. J Immunother Cancer 2021
8
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.